在MESA中Apo CIII蛋白质,血脂和心血管风险
Shripad Sinari1, Juraj Koska2, Yueming Hu3
1Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson (S.S., D.B.).
Arteriosclerosis, thrombosis, and vascular biology
|June 15, 2023
概括
脂蛋白CIII (Apo CIII) 的蛋白型组成影响脂质水平和心血管疾病风险. Apo CIII0b/III1比率反向预测心血管风险,独立于脂质和人口统计数据.
科学领域:
- 心血管科学 心血管科学
- 代谢研究研究 代谢研究
- 蛋白质组学是指蛋白质组学.
背景情况:
- 脂蛋白CIII (Apo CIII) 是甘油三代谢的关键调节剂,也是心血管风险的标志物.
- Apo CIII存在于四种主要蛋白质形式 (CIII0a,CIII0b,CIII1,CIII2) 中,具有不同的糖化,可能会以不同的方式影响脂蛋白代谢.
- 了解这些蛋白质的不同作用对于评估心血管风险至关重要.
研究的目的:
- 为了研究不同Apo CIII蛋白质和血脂类之间的关联.
- 确定Apo CIII蛋白质和发生心血管疾病风险之间的关系.
- 探索Apo CIII蛋白形组成如何与人口和临床因素相关.
主要方法:
- 使用质谱免疫试验量化Apo CIII蛋白质形式,对来自动脉样硬化多民族研究队列的5791名参与者进行了量化.
- 血脂被监测,心血管事件被判定超过16-17年的随访.
- 使用统计模型分析关联,并根据各种临床和人口因素进行调整.
主要成果:
- 阿波CIII蛋白形组成因年龄,性别,种族/民族,BMI和葡萄糖水平而有显著变化.
- 较高的CIII2/III1比率与较低的甘油三和较高的HDL相关,独立于其他因素.
- 虽然总的Apo CIII和CIII2/III1显示出与心血管风险的积极关联,但经过调整后,这种关联得到了减弱. 相反,CIII0b/III1比率显示出与心血管疾病风险的反向关联,即使在完全调整后.
结论:
- Apo CIII 蛋白形组成与人口和临床特征有明显的关系.
- 在预测未来的脂质配置和心血管疾病风险方面,Apo CIII蛋白质的特异性成分很重要.
- Apo CIII0b/III1比率成为心血管疾病风险的重要逆预测指标.
相关概念视频
01:25Blood Studies for Cardiovascular System III: Serum Lipid Profile
205
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
205
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
204
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
204
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
127
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
127
01:26Atherosclerosis III: Management
15
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
15
01:26Coronary Artery Disease IV: Preventive Measures
25
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
25
01:30Acute Coronary Syndrome III: Diagnostic Studies
11
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
11